Marco Vitoria

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. doi request reprint Simplification of antiretroviral therapy: a necessary step in the public health response to HIV/AIDS in resource-limited settings
    Marco Vitoria
    HIV Department, World Health Organization, Geneva, Switzerland
    Antivir Ther 19:31-7. 2014
  2. pmc Antiretroviral therapy response among HIV-2 infected patients: a systematic review
    Didier K Ekouevi
    Programme PACCI, Site ANRS, Abidjan, Cote d Ivoire
    BMC Infect Dis 14:461. 2014
  3. doi request reprint Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges
    Marco Vitoria
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    Curr Opin HIV AIDS 8:12-8. 2013
  4. doi request reprint The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives
    Marco Vitoria
    World Health Organization, HIV Dept, Geneva, Switzerland
    Am J Clin Pathol 131:844-8. 2009
  5. pmc Highly active antiretroviral treatment for the prevention of HIV transmission
    Reuben Granich
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    J Int AIDS Soc 13:1. 2010
  6. pmc Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
    Reuben Granich
    Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    Curr Opin HIV AIDS 5:298-304. 2010
  7. ncbi request reprint The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
    Charles F Gilks
    Department of HIV AIDS, World Health Organization, Geneva 1211, Switzerland
    Lancet 368:505-10. 2006
  8. doi request reprint Determinants of HIV drug resistance and public health implications in low- and middle-income countries
    Silvia Bertagnolio
    HIV Department, World Health Organization, Geneva, Switzerland
    Antivir Ther 17:941-53. 2012
  9. pmc Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis
    Reuben Granich
    Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
    Curr HIV Res 9:355-66. 2011
  10. pmc Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050
    Reuben Granich
    HIV AIDS Department, World Health Organization, Geneva, Switzerland
    PLoS ONE 7:e30216. 2012

Collaborators

Detail Information

Publications25

  1. doi request reprint Simplification of antiretroviral therapy: a necessary step in the public health response to HIV/AIDS in resource-limited settings
    Marco Vitoria
    HIV Department, World Health Organization, Geneva, Switzerland
    Antivir Ther 19:31-7. 2014
    ....
  2. pmc Antiretroviral therapy response among HIV-2 infected patients: a systematic review
    Didier K Ekouevi
    Programme PACCI, Site ANRS, Abidjan, Cote d Ivoire
    BMC Infect Dis 14:461. 2014
    ..We conducted a systematic review on treatment outcomes among HIV-2 infected patients on ART, focusing on the immunological and virological responses in adults...
  3. doi request reprint Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges
    Marco Vitoria
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    Curr Opin HIV AIDS 8:12-8. 2013
    ....
  4. doi request reprint The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives
    Marco Vitoria
    World Health Organization, HIV Dept, Geneva, Switzerland
    Am J Clin Pathol 131:844-8. 2009
    ..Investment in strategic information and public health laboratory network capacity strengthening are key actions to expand services to successfully address those diseases in heavily impacted countries...
  5. pmc Highly active antiretroviral treatment for the prevention of HIV transmission
    Reuben Granich
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    J Int AIDS Soc 13:1. 2010
    ..To explore HAART as a prevention strategy, we recommend further discussions to explore human rights and ethical considerations, clarify research priorities and review feasibility and acceptability issues...
  6. pmc Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
    Reuben Granich
    Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    Curr Opin HIV AIDS 5:298-304. 2010
    ..This review examines HAART as a potential tool for preventing HIV transmission...
  7. ncbi request reprint The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
    Charles F Gilks
    Department of HIV AIDS, World Health Organization, Geneva 1211, Switzerland
    Lancet 368:505-10. 2006
    ..Simplified operational guidelines, tools, and training materials enable clinical teams in primary-care and second-level facilities to deliver HIV prevention, HIV care, and ART, and to use a standardised patient-tracking system...
  8. doi request reprint Determinants of HIV drug resistance and public health implications in low- and middle-income countries
    Silvia Bertagnolio
    HIV Department, World Health Organization, Geneva, Switzerland
    Antivir Ther 17:941-53. 2012
    ..Additionally, we summarize the World Health Orgnization's global HIVDR surveillance and prevention strategy and describe resulting public health and policy implications...
  9. pmc Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis
    Reuben Granich
    Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
    Curr HIV Res 9:355-66. 2011
    ..This review analyzes the gaps and summarizes the evidence regarding ART in the prevention of HIV and TB...
  10. pmc Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050
    Reuben Granich
    HIV AIDS Department, World Health Organization, Geneva, Switzerland
    PLoS ONE 7:e30216. 2012
    ..Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa...
  11. doi request reprint Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis
    Nathan Ford
    aDepartment of HIV AIDS, World Health Organization Geneva, Switzerland bDepartment of Infectious Disease Epidemiology, Imperial College London, London, UK cStanford Prevention Research Center, Stanford University, Stanford, California, USA dHIV AIDS Unit, Infectious Disease Service, Geneva University Hospital, Geneva, Switzerland
    AIDS 28:2721-7. 2014
    ..We evaluated variations in completion rates for HIV postexposure prophylaxis (PEP) according to the exposure type (occupational, nonoccupational, and sexual assault), patient, and programme characteristics...
  12. ncbi request reprint Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens
    Françoise Renaud-Théry
    Department of HIV AIDS, World Health Organization, CH 1211 Geneva 27, Switzerland
    AIDS 21:S89-95. 2007
    ..To address the information gap on current use of antiretroviral drugs (ARTs) in developing countries...
  13. pmc Comparative efficacy of Lamivudine and emtricitabine: a systematic review and meta-analysis of randomized trials
    Nathan Ford
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    PLoS ONE 8:e79981. 2013
    ..Lamivudine and emtricitabine are considered equivalent by several guidelines, but evidence of comparable efficacy is conflicting...
  14. doi request reprint Optimization and simplification of antiretroviral therapy for adults and children
    Nathan Ford
    aHIV AIDS Department, World Health Organization, Geneva, Switzerland bDepartments of Medicine, Pharmacology, and International Health, Johns Hopkins University, Baltimore, Maryland, USA cDepartment of Pharmacological Research and Medicines Evaluation, Istituto Superiore di Sanita, Rome, Italy dClinton Health Access Initiative, Boston, USA
    Curr Opin HIV AIDS 8:591-9. 2013
    ..The review reflects on opportunities and challenges for HIV treatment optimization for the next 5 years...
  15. doi request reprint The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities
    Meg Doherty
    HIV Department, World Health Organization, Geneva, Switzerland
    Curr Opin HIV AIDS 8:528-34. 2013
    ..The review summarizes the key new recommendations of the WHO 2013 guidelines for antiretroviral therapy and describes the potential impact of these recommendations on the HIV epidemic...
  16. doi request reprint Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis
    Nathan Ford
    aHIV Department, World Health Organization, Geneva, Switzerland bEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland, USA cDepartment of Infectious Disease Epidemiology, Imperial College London, London, UK dHIV AIDS Unit, Infectious Disease Service, Geneva University Hospital eMédecins Sans Frontières, Geneva, Switzerland
    AIDS 28:S123-31. 2014
    ..The objective of this review is to update evidence on efavirenz safety in HIV-infected pregnant women to inform revision of the 2013 WHO guidelines for antiretroviral therapy in low and middle-income countries...
  17. pmc Antiretroviral therapy in prevention of HIV and TB: update on current research efforts
    Reuben Granich
    Antiretroviral Treatment and HIV Care, Department of HIV AIDS, Building D, 1st Floor, Room 1005, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
    Curr HIV Res 9:446-69. 2011
    ..The large number and wide variety of research projects emphasise the importance of this research issue and clearly demonstrate the potential for synergies, partnerships and coordination across funding agencies...
  18. pmc Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting
    Louisa Jones
    World Health Organization, Geneva, Switzerland
    Curr HIV Res 9:416-28. 2011
    ..ART programs should consider measuring the cost and impact of human rights and community support interventions as key aspects of successful programme expansion...
  19. doi request reprint Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure
    George W Rutherford
    aCochrane HIV AIDS Group, Global Health Sciences, University of California, San Francisco, San Francisco, California, USA bHIV Department, World Health Organization, Geneva, Switzerland
    AIDS 28:S161-9. 2014
    ..We systematically reviewed the performance of 2010 WHO immunologic and clinical criteria for predicting virologic failure in HIV-infected patients on antiretroviral therapy (ART)...
  20. doi request reprint The future role of CD4 cell count for monitoring antiretroviral therapy
    Nathan Ford
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa Electronic address
    Lancet Infect Dis 15:241-7. 2015
    ..However, in settings where both CD4 cell counts and viral load testing are routinely available, countries should consider reducing the frequency of CD4 cell counts or not doing routine CD4 monitoring for patients who are stable on ART. ..
  21. pmc Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countries
    Françoise Renaud-Théry
    Department of HIV AIDS, World Health Organization, 1211 Geneva, Switzerland
    AIDS Res Treat 2011:749041. 2011
    ....
  22. ncbi request reprint National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?
    Eduard J Beck
    HIV Department, World Health Organization, Geneva, Switzerland
    AIDS 20:1497-502. 2006
    ..To investigate the existence of national adult antiretroviral therapy (ART) guidelines in 43 World Health Organization (WHO) '3 by 5' focus countries and compare their content with the 2003 WHO ART guidelines...
  23. doi request reprint Optimal strategies for monitoring response to antiretroviral therapy in HIV-infected adults, adolescents, children and pregnant women: a systematic review
    Joseph D Tucker
    aUniversity of North Carolina Project China, Guangzhou, China bInstitute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA cLondon School of Hygiene and Tropical Medicine, London, UK dHIV Department, World Health Organization, Geneva, Switzerland Joseph D Tucker, Cedric H Bien and Philippa J Easterbrook contributed equally to this manuscript
    AIDS 28:S151-60. 2014
    ....
  24. pmc Preferred antiretroviral drugs for the next decade of scale up
    Isabelle Andrieux-Meyer
    Medecins Sans Frontieres, Geneva, Switzerland
    J Int AIDS Soc 15:17986. 2012
    ..This commentary reviews recommendations made in an expert consultation on treatment scale up in resource-limited settings...
  25. doi request reprint Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus
    Steven T Wiersma
    World Health Organization, FCH IVB, Geneva, Switzerland
    Liver Int 31:755-61. 2011
    ..In addition, a research agendum was developed focusing on issues related to prevention and treatment of chronic HBV in resource-constrained settings...